PreprintAll rights reservedbioRxiv
Molecular Mechanisms of Quizartinib Resistance in FLT3 Mutants
- 1School of Medicine, Zhejiang University
Related
- Molecular mechanisms and therapeutic strategies of immunotherapy resistance in esophageal cancer
- Endocrine resistance in HR+/HER2− breast cancer: molecular mechanisms and emerging therapeutic strategies
- Advances in Research on the Genotype–Phenotype Correspondence of Antibiotic Resistance in Helicobacter pylori and Its Molecular Mechanisms: A Narrative Review
- Autophagy in Pituitary Neuroendocrine Tumors (PitNETs): Molecular Mechanisms, Secretory Homeostasis, Therapeutic Resistance, and Translational Perspectives
- Flavonoids in cancer pharmacology: molecular mechanisms, tumor microenvironment regulation, and drug resistance
BibTeX
@misc{zhao2026molecular,
title = {{Molecular Mechanisms of Quizartinib Resistance in FLT3 Mutants}},
author = {D. Zhao and Y. Li and A. Vu and Y. Miao and X. Wang and B. Wang and Y. Qiao and S. Song and X. Yang and Z. Shao and J. Nan},
howpublished = {bioRxiv},
year = {2026},
month = nov,
doi = {10.64898/2026.11.09.765260},
url = {https://www.biorxiv.org/content/10.64898/2026.11.09.765260v1},
}
RIS
TY - UNPB
TI - Molecular Mechanisms of Quizartinib Resistance in FLT3 Mutants
AU - D. Zhao
AU - Y. Li
AU - A. Vu
AU - Y. Miao
AU - X. Wang
AU - B. Wang
AU - Y. Qiao
AU - S. Song
AU - X. Yang
AU - Z. Shao
AU - J. Nan
PY - 2026
DA - 2026/11/09
PB - bioRxiv
DO - 10.64898/2026.11.09.765260
UR - https://www.biorxiv.org/content/10.64898/2026.11.09.765260v1
ER -